Quality dimensions and items for guideline appraisal.

Table 2: Quality dimensions and items for guideline appraisal.

Quality dimensions / Item label	AHA, 2018	Australia, 2016	Canada, 2017	HEARTs, 2018	ESC/ESH, 2018	Ethiopia, 2016
1. Information retrieval
1.1. Health questions and outcomes	√	√	√	√	√	√
1.2. Literature search	√	√	√	√	√	X
1.3. Literature selection	√	√	√	√	√	X
2. Evaluation of evidence
2.1. Grading of evidence	√	√	√	PA	√	PA
2.2. Consistency b/n evidence & recommendations	√	√	√	PA	√	PA
3. Consideration of different perspectives
3.1. Norms and values	√	√	√	√	√	√
3.2. Expert knowledge	√	√	√	√	√	√
3.3. Patient perspectives	√	√	√	√	√	√
4. Formulation of recommendations
4.1. Formulation of recommendations	√	√	√	√	√	√
5. Transferability
5.1. Comparability	√	√	√	√	√	√
5.2. Costs	√	√	√	√	√	√
5.3. Barriers and facilitators	√	√	√	√	√	X
6. Presentation of guideline content
6.1. Benefits and harms	√	√	√	√	√	√
6.2. Link to evidence	√	√	√	√	√	X
7. Alternatives
7.1. Options for management	√	√	√	√	√	√
7.2. Exceptions	√	√	√	√	√	√
7.3. Patient preferences	√	√	√	√	√	X
8. Reliability
8.1. Independent Review	√	√	√	√	√	√
8.2. Pilot test	√	√	√	√	√	X
9. Scope
9.1. Rationale and objective	√	√	√	√	√	√
9.2. Guideline topic	√	√	√	√	√	√
9.3. Practice setting	√	√	√	√	√	√
9.4. Patient population	√	√	√	√	√	X
9.5. Provider population	√	√	√	√	√	√
10. Independence	√	√	√	√	√	√
10.1. Guideline development group	√	√	√	√	√	√
10.2. Guideline development organization & funding	√	√	√	√	√	√
10.3. Conflicts of interest	√	√	√	√	√	√
11. Clarity and presentation
11.1. Clarity	√	√	√	√	√	√
11.2. Presentation	√	√	√	√	√	√
12. Updating
12. 1. Currentness	√	√	√	√	√	X
12.2. Scheduled review	√	√	√	√	√	X
13. Dissemination, Implementation, Evaluation
13.1. Dissemination	√	√	√	√	√	√
13.2. Implementation	√	√	√	√	√	√
13.3. Evaluation	√	√	√	√	√	X

√: Yes; X: No; PA: Partially acceptable for guidelines that are copied from other guidelines.